2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC1876 | |||||||||||||||||||||||
Submitter : | Mr. Willis Langford | Date & Time: | 02/13/2006 03:02:18 | |||||||||||||||||||||
Organization : | Mr. Willis Langford | |||||||||||||||||||||||
Category : | Dietary Supplement Industry | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Dear Sirs:
I perceive FDA to be charged with protection of citizen's health and well-being. I observe too often that FDA policies protect Industry, particularly the huge, multinational drug industries. Such is the case developing in this proposal. The US public citizen must continue to be free to judge for himself what is good for his health and well-being, and doctors must be left free to prescribe what works to safely enhance the patient's well-being. Unless considerable evidence is available to the contrary, showing disability and death through the availability and responsible use of bio-identical hormones, this request for regulatory action must be defeated/rejected. Sincerely, Lcdr Willis S. Langford, USNR,(R) 3579 Santa Maria Street Oceanside, CA 92056 (760) 439-7884 WillissL@asol.com Researcher, Author, and consultant | ||||||||||||||||||||||||